Publicaciones en las que colabora con EWA ZDZISLAWA RACZKA WOJTOWICKA (11)

2003

  1. Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: A population pharmacokinetic model

    Gerontology, Vol. 49, Núm. 4, pp. 205-214

2002

  1. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor

    Pharmaceutical Research, Vol. 19, Núm. 9, pp. 1310-1316

  2. Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats

    Journal of Pharmaceutical Sciences, Vol. 91, Núm. 1, pp. 41-52

2001

  1. Altered disposition and effect of lerisetron in rats with elevated alpha1-acid glycoprotein levels

    Pharmaceutical Research, Vol. 18, Núm. 6, pp. 838-845

  2. The synthesis and testing of anti-cancer therapeutic nanodevices

    Biomedical Microdevices, Vol. 3, Núm. 1, pp. 61-69

2000

  1. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector

    Human Gene Therapy, Vol. 11, Núm. 10, pp. 1385-1395

1999

  1. Anti-oedematous effect of hidrosmin on thermal injury oedema and acute lymphoedema in the rat hind leg

    Pharmacy and Pharmacology Communications, Vol. 5, Núm. 2, pp. 133-136

  2. Effects of intravenous administration of prostacyclin on regional blood circulation in awake rats

    British Journal of Pharmacology, Vol. 126, Núm. 6, pp. 1325-1332

1998

  1. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

    Cancer Chemotherapy and Pharmacology, Vol. 42, Núm. 5, pp. 418-422

  2. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo

    Gene Therapy, Vol. 5, Núm. 10, pp. 1333-1339

1993

  1. Papel de las prostaglandinas en la regulación del flujo sanguíneo cerebral

    Papel de las prostaglandinas en la regulación del flujo sanguíneo cerebral